With the rise of decentralized and point-of-care testing, IVD manufacturers face a new reality, where speed and resilience must coexist. Product development and commercialization are becoming complex due to:
The most successful IVD OEMs are those that integrate regulatory compliance and adaptability into their product architecture from the start.
This article presents a holistic framework for IVD systems development and scale-up. It examines the market forces driving diagnostic innovation and the bottlenecks hindering commercialization. Furthermore, the paper delves into the strategic levers that enable sustained compliance and performance.
A featured case study demonstrates how an IVD OEM reduced rework and accelerated time-to-launch by partnering early with an IVD contract development and manufacturing organization (CDMO).
By embedding foresight into every stage of development, IVD companies can:
See how leading diagnostics companies accelerate product development, streamline submissions, and strengthen supply chain continuity through Syrma Johari MedTech’s resilience-driven IVD manufacturing model.
